128
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Rubella-related Intermediate Uveitis in Pregnancy—A Rare Presentation

, MBBS & , FRCS (Glasgow)
Pages 156-157 | Received 27 Oct 2010, Accepted 13 Jan 2011, Published online: 19 May 2011
 

Abstract

Purpose: To report a rare case of intermediate uveitis following rubella infection in pregnancy.

Design: Case report.

Methods: A 35-year-old pregnant woman, at 24 weeks of gestation, presented with sudden floaters and blurring of vision of the left eye. Ocular examination revealed vitritis 1–2+ with no retinal involvement. Rubella serology showed a high IgG titr eof 268 IU/mL. Treatment with periocular steroids (posterior subtenon triamcinalone) injection into the left eye was initiated.

Results: Improvement of vision with resolution of the vitritis was seen after 3 weeks. Repeat rubella IgG titer dropped to 20.4 IU/mL. Obstetrics evaluation of the fetus remained normal.

Conclusions: Rubella-related intermediate uveitis is a very rare presentation during pregnancy. It is worthwhile to investigate for rubella infections in pregnant patients complaining of recent onset of visual disturbances. This type of intermediate uveitis can be treated successfully with minimal ocular complications if recognized early.

ACKNOWLEDGMENT

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.